ArticleJournal for immunotherapy of cancer2021

Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies.

Chaoting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.